Desiderosmia-Associated Iron Deficiency: A Case Report and Review of the Literature
Abstract
Iron deficiency is the most common cause of anemia worldwide, yet desiderosmia remains rarely described as one of its manifestations. The term "desiderosmia" was first proposed in a case series by Hansen et al. to describe compulsive olfactory cravings for specific scents observed in three symptomatic patients with iron deficiency, derived from the Latin word "desiderare" for desire and the Greek word "osme" for smell. Desiderosmia appears to be closely related to pica, a common manifestation of iron deficiency, though the key difference is that patients report olfactory cravings without the desire to consume the scent-producing substance. As far as the authors of this report are aware, the number of published cases of desiderosmia is extremely scarce, and the term itself has yet to become recognized in medical literature, owing to its novelty. We report the case of a 32-year-old woman with menorrhagia and iron deficiency anemia (IDA) refractory to oral ferrous sulfate despite adherence. Despite her hemoglobin improving from 9.1 to 9.9 g/dL (reference range: 12-15.5 g/dL), her ferritin remained critically low at 1 ng/mL (reference range: 30-400 ng/mL). At that time, she developed an intense urge to smell pine-scented cleaning products, alongside migraines and restless leg syndrome, hypothesized to be neuropsychological symptoms linked to altered CNS iron homeostasis. We speculate that desiderosmia may share a similar neurological mechanism, correlating more closely with the…
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.